Litcius/Paper detail

Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study

Alejo Rodríguez‐Vida, Pablo Maroto, Albert Font, Cristina Martín, Begoña Mellado, Alex Corbera, Mayra Orrillo, Òscar Reig, Rosa Querol, Alejandro Ríos-Hoyo, Laia Querol Cano, Judith Alonso, Gemma Martínez, Susana Galtes, Álvaro Taus, Maria Martinez‐García, Núria Juanpere, Óscar Juan, Joaquim Bellmunt

2022British Journal of Cancer13 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCarboplatinInternal medicineProstate cancerOncologyClinical endpointAvelumabIpilimumabPopulationTaxaneUrologySurgeryCancerChemotherapyClinical trialImmunotherapyNivolumabBreast cancerEnvironmental healthCisplatinProstate Cancer Treatment and ResearchCancer Immunotherapy and BiomarkersProstate Cancer Diagnosis and Treatment
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study | Litcius